Search research articles
Contact Us
Filters
Showing results (541-550 of 659) with videos related to
Page
of 66
Sort By:
CMAJ Open
|
April 7, 2016
Effect of physician specialist alternative payment plans on administrative health data in Calgary: a validation study
Ceara Tess Cunningham, Nathalie Jetté, Bing Li, et al.
Breast Cancer Research and Treatment
|
May 10, 2019
Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO)
Christel Fontaine, Vincent Renard, Heidi Van den Bulk, et al.
Schizophrenia Research
|
May 26, 2018
Evidence that the association of childhood trauma with psychosis and related psychopathology is not explained by gene-environment correlation: A monozygotic twin differences approach
Aleksandra Lecei, Jeroen Decoster, Marc De Hert, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 16, 2015
Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma
Jacques De Grève, Teresa Moran, Marie-Pascale Graas, et al.
The Lancet. Healthy Longevity
|
September 13, 2022
Is cancer biology different in older patients?
Yannick Van Herck, Annelies Feyaerts, Shabbir Alibhai, et al.
ACS Omega
|
March 4, 2024
Copper-Cystine Biohybrid-Embedded Nanofiber Aerogels Show Antibacterial and Angiogenic Properties
Anik Karan, Navatha Shree Sharma, Margarita Darder, et al.
ESMO Open
|
October 18, 2023
Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study
S Joris, H Denys, J Collignon, et al.
Annals of Plastic Surgery
|
September 13, 2019
Appalachian Status Is a Negative Predictor of Breast Reconstruction Following Breast Cancer Resection
Ryan C DeCoster, Megan A Stout, Jack C Burns, et al.
ESMO Open
|
May 9, 2026
Efficacy of olaparib in advanced cancers with somatic or germline mutations in BAP1, BARD1, BRIP1 and PALB2
S Joris, H Denys, J Collignon, et al.
Journal of Pain and Symptom Management
|
August 23, 2025
The MyPath Pain Pathway: developing a digital patient-centred care pathway for cancer pain
Morena Shkodra, Amaia Urrizola, Marie Fallon, et al.
Page
of 66
Search research articles
Search
Showing results (541-550 of 659) with videos related to
Sort By:
Page
of 66
CMAJ Open
|
April 7, 2016
Effect of physician specialist alternative payment plans on administrative health data in Calgary: a validation study
Ceara Tess Cunningham, Nathalie Jetté, Bing Li, et al.
Breast Cancer Research and Treatment
|
May 10, 2019
Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO)
Christel Fontaine, Vincent Renard, Heidi Van den Bulk, et al.
Schizophrenia Research
|
May 26, 2018
Evidence that the association of childhood trauma with psychosis and related psychopathology is not explained by gene-environment correlation: A monozygotic twin differences approach
Aleksandra Lecei, Jeroen Decoster, Marc De Hert, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 16, 2015
Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma
Jacques De Grève, Teresa Moran, Marie-Pascale Graas, et al.
The Lancet. Healthy Longevity
|
September 13, 2022
Is cancer biology different in older patients?
Yannick Van Herck, Annelies Feyaerts, Shabbir Alibhai, et al.
ACS Omega
|
March 4, 2024
Copper-Cystine Biohybrid-Embedded Nanofiber Aerogels Show Antibacterial and Angiogenic Properties
Anik Karan, Navatha Shree Sharma, Margarita Darder, et al.
ESMO Open
|
October 18, 2023
Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study
S Joris, H Denys, J Collignon, et al.
Annals of Plastic Surgery
|
September 13, 2019
Appalachian Status Is a Negative Predictor of Breast Reconstruction Following Breast Cancer Resection
Ryan C DeCoster, Megan A Stout, Jack C Burns, et al.
ESMO Open
|
May 9, 2026
Efficacy of olaparib in advanced cancers with somatic or germline mutations in BAP1, BARD1, BRIP1 and PALB2
S Joris, H Denys, J Collignon, et al.
Journal of Pain and Symptom Management
|
August 23, 2025
The MyPath Pain Pathway: developing a digital patient-centred care pathway for cancer pain
Morena Shkodra, Amaia Urrizola, Marie Fallon, et al.
Page
of 66